• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本糖尿病学会1型糖尿病委员会报告:缓慢进展性1型糖尿病(SPIDDM)新诊断标准(2023年)(英文版)

New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).

作者信息

Shimada Akira, Kawasaki Eiji, Abiru Norio, Awata Takuya, Oikawa Yoichi, Osawa Haruhiko, Kajio Hiroshi, Kozawa Junji, Takahashi Kazuma, Chujo Daisuke, Noso Shinsuke, Fukui Tomoyasu, Miura Junnosuke, Yasuda Kazuki, Yasuda Hisafumi, Imagawa Akihisa, Ikegami Hiroshi

机构信息

Department of Endocrinology and Diabetes, School of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma, Saitama Japan.

Diabetes Center, Shin-Koga Hospital, Fukuoka, Japan.

出版信息

Diabetol Int. 2024 Jan 8;15(1):1-4. doi: 10.1007/s13340-023-00679-1. eCollection 2024 Jan.

DOI:10.1007/s13340-023-00679-1
PMID:38264233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10800325/
Abstract

The diagnostic criteria for slowly progressive type 1 diabetes (slowly progressive insulin-dependent diabetes mellitus; SPIDDM) have been revised by the Committee on Type 1 Diabetes of the Japan Diabetes Society. All of the following three criteria must be met for "a definitive diagnosis of SPIDDM": (1) presence of anti-islet autoantibodies at some point in time during the disease course; (2) absence of ketosis or ketoacidosis at the diagnosis of diabetes with no requirement of insulin treatment to correct hyperglycemia immediately after diagnosis in principle; and (3) gradual decrease of insulin secretion over time, with insulin treatment required at more than 3 months after diagnosis, and presence of severe endogenous insulin deficiency (fasting serum C-peptide immunoreactivity < 0.6 ng/mL) at the last observed point in time. When a patient fulfills the only (1) and (2), but not (3), he/she is diagnosed with "SPIDDM (probable)" because the diabetes is non-insulin-dependent state.

摘要

日本糖尿病学会1型糖尿病委员会修订了缓慢进展性1型糖尿病(缓慢进展性胰岛素依赖型糖尿病;SPIDDM)的诊断标准。要“确诊SPIDDM”,必须满足以下所有三项标准:(1)在病程中的某个时间点存在抗胰岛自身抗体;(2)糖尿病诊断时不存在酮症或酮症酸中毒,原则上诊断后无需立即使用胰岛素治疗来纠正高血糖;(3)胰岛素分泌随时间逐渐减少,诊断后3个月以上需要胰岛素治疗,且在最后观察时间点存在严重的内源性胰岛素缺乏(空腹血清C肽免疫反应性<0.6 ng/mL)。当患者仅满足(1)和(2),但不满足(3)时,因其糖尿病处于非胰岛素依赖状态,故诊断为“可能的SPIDDM”。

相似文献

1
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).日本糖尿病学会1型糖尿病委员会报告:缓慢进展性1型糖尿病(SPIDDM)新诊断标准(2023年)(英文版)
Diabetol Int. 2024 Jan 8;15(1):1-4. doi: 10.1007/s13340-023-00679-1. eCollection 2024 Jan.
2
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).2023 年新诊断标准(缓慢进展型 1 型糖尿病):日本糖尿病学会 1 型糖尿病委员会报告(英文版)。
J Diabetes Investig. 2024 Feb;15(2):254-257. doi: 10.1111/jdi.14121. Epub 2024 Jan 7.
3
Trends in endogenous insulin secretion capacity and anti-islet autoantibody titers in two childhood-onset slowly progressive insulin-dependent diabetes mellitus cases.两例儿童期起病的缓慢进展型胰岛素依赖型糖尿病患者内源性胰岛素分泌能力及抗胰岛自身抗体滴度的变化趋势
Clin Pediatr Endocrinol. 2024 Oct;33(4):238-243. doi: 10.1297/cpe.2024-0039. Epub 2024 Aug 13.
4
Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.抗谷氨酸脱羧酶(GAD)抗体ELISA检测呈阳性的缓慢进展性胰岛素依赖型(1型)糖尿病可能与未来的胰岛素依赖状态密切相关。
Endocr J. 2017 Feb 27;64(2):163-170. doi: 10.1507/endocrj.EJ16-0328. Epub 2016 Oct 18.
5
Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives.缓慢进展型1型糖尿病:当前认知与未来展望
Diabetes Metab Syndr Obes. 2019 Nov 28;12:2461-2477. doi: 10.2147/DMSO.S191007. eCollection 2019.
6
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version).实践指南:关于疑似缓慢进展性1型糖尿病(SPIDDM;可能)病例治疗的声明(英文版)
Diabetol Int. 2024 Nov 12;16(1):1-6. doi: 10.1007/s13340-024-00753-2. eCollection 2025 Jan.
7
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version).实践指南:关于疑似缓慢进展性1型糖尿病(SPIDDM;可能)病例治疗的声明(英文版)
J Diabetes Investig. 2025 Jan;16(1):163-168. doi: 10.1111/jdi.14267. Epub 2024 Nov 12.
8
Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.非胰岛素依赖型谷氨酸脱羧酶(GAD)自身抗体阳性糖尿病的临床及遗传特征:日本全国性调查
PLoS One. 2016 May 13;11(5):e0155643. doi: 10.1371/journal.pone.0155643. eCollection 2016.
9
Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus.急性起病 1 型糖尿病的诊断标准(2012 年):日本糖尿病学会暴发性及急性起病 1 型糖尿病研究委员会报告。
J Diabetes Investig. 2014 Feb 12;5(1):115-8. doi: 10.1111/jdi.12119. Epub 2013 Aug 13.
10
Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.糖尿病分类与诊断标准委员会报告。
Diabetes Res Clin Pract. 2002 Jan;55(1):65-85. doi: 10.1016/s0168-8227(01)00365-5.

引用本文的文献

1
Utility of long-term systolic blood pressure variability for predicting the development of type 2 diabetes mellitus.长期收缩压变异性对预测2型糖尿病发生的效用。
Nagoya J Med Sci. 2025 May;87(2):220-236. doi: 10.18999/nagjms.87.2.220.
2
Lifestyle and Clinical Predictors of Glial Cell Line-Derived Neurotrophic Factor Expression in Lumbosacral Stenosis-Related Ligamentum Flavum Degeneration.腰骶部狭窄相关黄韧带退变中胶质细胞源性神经营养因子表达的生活方式及临床预测因素
Biomedicines. 2025 Jun 23;13(7):1530. doi: 10.3390/biomedicines13071530.
3
A case of latent autoimmune diabetes in the young positive for zinc transporter 8 antibody with type 2 diabetes characteristics.1例具有2型糖尿病特征的年轻隐匿性自身免疫性糖尿病患者锌转运体8抗体呈阳性。
Clin Pediatr Endocrinol. 2025 Jul;34(3):193-199. doi: 10.1297/cpe.2024-0083. Epub 2025 May 30.
4
Classification of Japanese type 1 diabetes based on clinical phenotypes and its association with diabetic complications: Across-sectional study.基于临床表型的日本1型糖尿病分类及其与糖尿病并发症的关联:一项横断面研究。
J Diabetes Investig. 2025 Sep;16(9):1653-1662. doi: 10.1111/jdi.70108. Epub 2025 Jul 2.
5
Clinical features among adult-onset type 1 diabetes, distribution of subtypes, and differences in probable and definite slowly progressive insulin-dependent diabetes mellitus: A single hospital-based study over a 13-year period.成人隐匿性自身免疫性糖尿病的临床特征、亚型分布以及可能的和确诊的缓慢进展性胰岛素依赖型糖尿病之间的差异:一项为期13年的单中心医院研究
J Diabetes Investig. 2025 May;16(5):952-958. doi: 10.1111/jdi.70012. Epub 2025 Mar 7.
6
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version).实践指南:关于疑似缓慢进展性1型糖尿病(SPIDDM;可能)病例治疗的声明(英文版)
Diabetol Int. 2024 Nov 12;16(1):1-6. doi: 10.1007/s13340-024-00753-2. eCollection 2025 Jan.
7
Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitus.线粒体DNA 3243突变可能与缓慢进展型1型糖尿病患者锌转运体8自身抗体阳性有关。
Diabetol Int. 2024 Nov 21;16(1):188-193. doi: 10.1007/s13340-024-00776-9. eCollection 2025 Jan.
8
Slow progression of type 1 diabetes associated with pembrolizumab and lenvatinib combination therapy in a patient with probable slowly progressive type 1 diabetes mellitus and endometrial cancer.帕博利珠单抗与乐伐替尼联合治疗可能为缓慢进展型1型糖尿病合并子宫内膜癌患者时1型糖尿病的缓慢进展
Diabetol Int. 2024 Oct 29;16(1):169-174. doi: 10.1007/s13340-024-00771-0. eCollection 2025 Jan.
9
Mortality rate and standardized mortality ratio of childhood-onset type 1 diabetes according to incidentally detected non-acute-onset or acute-onset subtype, sex, and onset age: A cohort study.根据偶然发现的非急性起病或急性起病亚型、性别和起病年龄分析儿童期发病的1型糖尿病的死亡率和标准化死亡比:一项队列研究。
Clin Pediatr Endocrinol. 2025 Jan;34(1):83-88. doi: 10.1297/cpe.2024-0050. Epub 2024 Sep 16.
10
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version).实践指南:关于疑似缓慢进展性1型糖尿病(SPIDDM;可能)病例治疗的声明(英文版)
J Diabetes Investig. 2025 Jan;16(1):163-168. doi: 10.1111/jdi.14267. Epub 2024 Nov 12.

本文引用的文献

1
Heterogeneity and endotypes in type 1 diabetes mellitus.1 型糖尿病的异质性和内型。
Nat Rev Endocrinol. 2023 Sep;19(9):542-554. doi: 10.1038/s41574-023-00853-0. Epub 2023 Jun 19.
2
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.成人隐匿性自身免疫性糖尿病的管理:国际专家小组的共识声明。
Diabetes. 2020 Oct;69(10):2037-2047. doi: 10.2337/dbi20-0017. Epub 2020 Aug 26.
3
Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives.缓慢进展型1型糖尿病:当前认知与未来展望
Diabetes Metab Syndr Obes. 2019 Nov 28;12:2461-2477. doi: 10.2147/DMSO.S191007. eCollection 2019.
4
Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).二肽基肽酶-4抑制剂西他列汀对非胰岛素依赖期缓慢进展1型糖尿病(SPIDDM)的可能长期疗效:一项开放标签随机对照试验(SPAN-S)
Diabetes Ther. 2017 Oct;8(5):1123-1134. doi: 10.1007/s13300-017-0299-7. Epub 2017 Sep 19.
5
Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.非胰岛素依赖型谷氨酸脱羧酶(GAD)自身抗体阳性糖尿病的临床及遗传特征:日本全国性调查
PLoS One. 2016 May 13;11(5):e0155643. doi: 10.1371/journal.pone.0155643. eCollection 2016.
6
Latent autoimmune diabetes in the young.成人隐匿性自身免疫性糖尿病
Clin Med (Lond). 2008 Oct;8(5):552-3. doi: 10.7861/clinmedicine.8-5-552.
7
Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.胰岛素对缓慢进展型胰岛素依赖型(1型)糖尿病的干预作用
J Clin Endocrinol Metab. 2008 Jun;93(6):2115-21. doi: 10.1210/jc.2007-2267. Epub 2008 Apr 8.
8
Incidence of children with slowly progressive form of type 1 diabetes detected by the urine glucose screening at schools in the Tokyo Metropolitan Area.东京都地区学校通过尿糖筛查检测出的1型糖尿病缓慢进展型患儿的发病率。
Diabetes Res Clin Pract. 2008 Jun;80(3):473-6. doi: 10.1016/j.diabres.2008.01.029. Epub 2008 Mar 21.
9
Immunogenetic and clinical characterization of slowly progressive IDDM.缓慢进展型胰岛素依赖型糖尿病的免疫遗传学及临床特征
Diabetes Care. 1993 May;16(5):780-8. doi: 10.2337/diacare.16.5.780.